Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.48% | -19.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.48% | -19.78% | |||
| Cost of Revenue | 5.66% | -16.88% | |||
| Gross Profit | -3.79% | 13.67% | |||
| SG&A Expenses | 7.54% | -4.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.11% | -14.15% | |||
| Operating Income | -5.26% | 10.22% | |||
| Income Before Tax | -8.30% | 10.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.51% | 13.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.51% | 13.80% | |||
| EBIT | -5.26% | 10.22% | |||
| EBITDA | -5.28% | 10.25% | |||
| EPS Basic | -4.49% | 23.42% | |||
| Normalized Basic EPS | -5.26% | 20.53% | |||
| EPS Diluted | -4.49% | 23.42% | |||
| Normalized Diluted EPS | -5.26% | 20.53% | |||
| Average Basic Shares Outstanding | 2.89% | 12.56% | |||
| Average Diluted Shares Outstanding | 2.89% | 12.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||